Aldeyra Therapeutics, Inc.

Historical 13F Holders

Symbol
ALDX
CUSIP
01438T106
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 14 1.05 M $3.43 M
2023 Q4 110 35.3 M $124 M
2023 Q3 127 37.8 M $252 M
2023 Q2 132 39.0 M $327 M
2023 Q1 119 35.6 M $353 M
2022 Q4 104 34.3 M $239 M
2022 Q3 100 39.4 M $210 M
2022 Q2 104 36.9 M $147 M
2022 Q1 124 38.7 M $172 M
2021 Q4 142 46.6 M $187 M
2021 Q3 135 39.7 M $349 M
2021 Q2 145 55.2 M $625 M
2021 Q1 117 40.4 M $480 M
2020 Q4 107 22.7 M $157 M
2020 Q3 90 23.8 M $176 M
2020 Q2 90 14.8 M $61.6 M
2020 Q1 76 16.8 M $41.4 M
2019 Q4 81 18.0 M $105 M
2019 Q3 76 16.9 M $89.0 M
2019 Q2 86 17.0 M $102 M
2019 Q1 90 16.4 M $148 M
2018 Q4 81 17.4 M $144 M
2018 Q3 104 18.2 M $251 M
2018 Q2 68 12.2 M $96.6 M
2018 Q1 46 10.3 M $77.1 M
2017 Q4 38 9.78 M $66.5 M
2017 Q3 36 9.22 M $66.4 M
2017 Q2 27 7.45 M $34.8 M
2017 Q1 26 8.81 M $42.5 M
2016 Q4 21 6.14 M $32.8 M
2016 Q3 22 6.11 M $47.9 M
2016 Q2 25 6.36 M $36.2 M
2016 Q1 28 4.37 M $18.3 M
2015 Q4 21 4.43 M $30.0 M
2015 Q3 23 5.29 M $30.8 M
2015 Q2 24 4.23 M $32.9 M
2015 Q1 15 1.69 M $17.4 M
2014 Q4 5 870 k $6.28 M
2014 Q3 7 859 k $5.16 M
2014 Q2 7 852 k $5.64 M